• H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 5629, Pathway for Biosimilars Act S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 5839, Safeguarding America's Pharmaceuticals Act of 2008
• House Concurrent Resolution 312 FY09 Budget Resolution Senate Concurrent Resolution 70 FY09 Budget Resolution Drug Importation Comparative EffectivenessLHHS Appropriations - drug importation Homeland Appropriations - drug importation Agriculture Appropriations - drug importation H.R. 2638, Consolidated Security, Disaster Assistance, and Continuing Appropriations Act, 2009
• H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion H. R. 3162, Children's Health and Medicare Protection Act of 2007 H. R. 4, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions H. R. 5480, Medicare Funding Warning Response Act of 2008S. 1376, 340B Program Improvement and Integrity Act of 2007, 340B drug price expansion S. 2029, Pathway for Biosimilars Act S. 2662, Medicare Funding Warning Response Act of 2008 S. 3, Medicare Prescription Drug Price Negotiation Act, Medicare noninterference provisions S. 3101, Medicare Improvements for Patients and Providers Act of 2008 H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008 Comparative Effectiveness
• S. 1145, Patent Reform Act of 2007, entire bill H. R. 1908, Patent Reform Act of 2007, entire bill S. 3600, Patent Reform Act of 2008
• FY09 LHHS Appropriations bill

Duration: January 1, 2007 to July 25, 2008

General Issues: Pharmacy, Budget/Appropriations, Medicare/Medicaid, Copyright/Patent/Trademark, Medical/Disease Research/Clinical Labs, Health Issues

Spending: about $0 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate, Food & Drug Administration (FDA), Centers For Medicare and Medicaid Services (CMS), Y Y Food and Drug Administration, Y Y, Y Y Centers for Medicare and Medicaid Services